Correlation Between Checkpoint Therapeutics and Bio Path
Can any of the company-specific risk be diversified away by investing in both Checkpoint Therapeutics and Bio Path at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Checkpoint Therapeutics and Bio Path into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Checkpoint Therapeutics and Bio Path Holdings, you can compare the effects of market volatilities on Checkpoint Therapeutics and Bio Path and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Checkpoint Therapeutics with a short position of Bio Path. Check out your portfolio center. Please also check ongoing floating volatility patterns of Checkpoint Therapeutics and Bio Path.
Diversification Opportunities for Checkpoint Therapeutics and Bio Path
-0.54 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Checkpoint and Bio is -0.54. Overlapping area represents the amount of risk that can be diversified away by holding Checkpoint Therapeutics and Bio Path Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bio Path Holdings and Checkpoint Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Checkpoint Therapeutics are associated (or correlated) with Bio Path. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bio Path Holdings has no effect on the direction of Checkpoint Therapeutics i.e., Checkpoint Therapeutics and Bio Path go up and down completely randomly.
Pair Corralation between Checkpoint Therapeutics and Bio Path
Given the investment horizon of 90 days Checkpoint Therapeutics is expected to generate 0.77 times more return on investment than Bio Path. However, Checkpoint Therapeutics is 1.29 times less risky than Bio Path. It trades about 0.07 of its potential returns per unit of risk. Bio Path Holdings is currently generating about -0.16 per unit of risk. If you would invest 362.00 in Checkpoint Therapeutics on September 14, 2024 and sell it today you would earn a total of 18.00 from holding Checkpoint Therapeutics or generate 4.97% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Checkpoint Therapeutics vs. Bio Path Holdings
Performance |
| Timeline |
| Checkpoint Therapeutics |
| Bio Path Holdings |
Checkpoint Therapeutics and Bio Path Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Checkpoint Therapeutics and Bio Path
The main advantage of trading using opposite Checkpoint Therapeutics and Bio Path positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Checkpoint Therapeutics position performs unexpectedly, Bio Path can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bio Path will offset losses from the drop in Bio Path's long position.| Checkpoint Therapeutics vs. Mustang Bio | Checkpoint Therapeutics vs. Reviva Pharmaceuticals Holdings | Checkpoint Therapeutics vs. Fortress Biotech Pref | Checkpoint Therapeutics vs. Kodiak Sciences |
| Bio Path vs. Capricor Therapeutics | Bio Path vs. NextCure | Bio Path vs. Pulmatrix | Bio Path vs. Crinetics Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Other Complementary Tools
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |